Comparing Single Dose and Multiple Dose of Dexamethasone Post TKA
Efficacy of Intravenous Dexamethasone Injection Given 12 and 24 Hours for Pain After Total Knee Arthroplasty: A Prospective Randomized Clinical Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the efficacy of single dose and double dose of dexamethasone after primary total knee replacement. The main question\[s\] it aims to answer \[is/are\]: Does 24 hours-interval of double dose of dexamethasone have better analgesic effect than single dose and 12 hours interval of double dose of dexamethasone after primary total joint replacement? Researchers will compare double dose of dexamethasone group to see if \[insert effects\]. Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 23, 2022
CompletedFirst Submitted
Initial submission to the registry
March 24, 2024
CompletedFirst Posted
Study publicly available on registry
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedApril 9, 2025
April 1, 2024
3.6 years
March 24, 2024
April 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain at rest and motion
Using visual analog scale 0-10 (0 means best, 10 means worst)
At 6 hour, 12 hour, 18 hour, 24 hour, 30 hour, 36 hour, 42 hour, 48 hour, 54 hour, 60 hour, 66 hour and 72 hour after surgery
Secondary Outcomes (7)
Nausea and vomiting
At 24 hour, 48 hour and 72 hour after surgery
Morphine consumption
At 24 hour, 48 hour and 72 hour after surgery
Blood sugar level
At 24 hour and 48 hour after surgery
CRP level
At 24 hour and 48 hour after surgery
Range of motion
At 24 hour and 48 hour after surgery
- +2 more secondary outcomes
Study Arms (3)
Group 1
ACTIVE COMPARATORPreoperative - Dexamethasone 0.15 mg/kg injection by the anesthesiologist 30 minutes before surgery. Postoperative 12 hr - Normal saline solution injection Postoperative 24 hr - Normal saline solution injection
Group 2
ACTIVE COMPARATORPreoperative - Dexamethasone 0.15 mg/kg injection by the anesthesiologist 30 minutes before surgery. Postoperative 12 hr - Dexamethasone 0.15 mg/kg IV at 12 hours post operation Postoperative 24 hr - Normal saline solution injection
Group 3
ACTIVE COMPARATORPreoperative - Dexamethasone 0.15 mg/kg injection by the anesthesiologist 30 minutes before surgery. Postoperative 12 hr - Normal saline solution injection Postoperative 24 hr - Dexamethasone 0.15 mg/kg IV at 24 hours post operation
Interventions
Dexamethasone 0.15 mg/kg IV before surgery Dexamethasone 0.15 mg/kg IV at 12 hours post operation
Dexamethasone 0.15 mg/kg IV before surgery Dexamethasone 0.15 mg/kg IV at 24 hours post operation
Eligibility Criteria
You may qualify if:
- Diagnosis of primary osteoarthritis of knee joint
- Undergo unilateral primary total knee replacement
- Age between 50-85 years old
You may not qualify if:
- Allergy to dexamethasone
- History of long term corticosteroid used
- New York heart association (NYHA) class \> II
- Type 2 Diabetes mellitus that had HbA1c \> 7 % or FBS \> 200 mg/dl
- Chronic kidney disease \> stage III or eGFR \< 60
- Cirrhosis Child class B or C
- Cannot use pain controlled as protocol
- History of previous knee surgery
- History of previous septic arthritis at knee joint
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thammasat University Hospital
Khlong Luang, Changwat Pathum Thani, 12120, Thailand
Related Publications (1)
Xu H, Zhang S, Xie J, Lei Y, Cao G, Pei F. Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study. J Arthroplasty. 2018 Nov;33(11):3448-3454. doi: 10.1016/j.arth.2018.06.031. Epub 2018 Jul 4.
PMID: 30033064BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
March 24, 2024
First Posted
April 1, 2024
Study Start
March 23, 2022
Primary Completion
October 31, 2025
Study Completion
October 31, 2025
Last Updated
April 9, 2025
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share